News & Updates

Polypharmacy in IBD interferes with treatment adherence, therapeutic success
Polypharmacy in IBD interferes with treatment adherence, therapeutic success
14 Mar 2022 byStephen Padilla

Polypharmacy (PP) arises in nearly one in five patients with inflammatory bowel disease (IBD), particularly in older adults and those with comorbidity, according to a study, adding that PP can complicate adherence to treatment and therapeutic success.

Polypharmacy in IBD interferes with treatment adherence, therapeutic success
14 Mar 2022
L-arginine, tadalafil boost Li-ESWT effect for ED
L-arginine, tadalafil boost Li-ESWT effect for ED
14 Mar 2022 byAudrey Abella

In men with erectile dysfunction (ED), adjuvant daily oral therapy with L-arginine and tadalafil was effective and safe in enhancing the efficacy and duration of benefits of low-intensity extracorporeal shockwave therapy (Li-ESWT), a study has shown.

L-arginine, tadalafil boost Li-ESWT effect for ED
14 Mar 2022
Adalimumab–methotrexate combo better than adalimumab monotherapy in psoriasis
Adalimumab–methotrexate combo better than adalimumab monotherapy in psoriasis
14 Mar 2022

In the treatment of patients with psoriasis, the combination of adalimumab plus methotrexate is more beneficial than adalimumab alone, reducing antidrug antibody formation and inducing slightly better response, drug survival, and higher serum trough concentrations, according to a study.

Adalimumab–methotrexate combo better than adalimumab monotherapy in psoriasis
14 Mar 2022
Pregnancies exposed to tramadol not at heightened risk of miscarriage, congenital malformations
Pregnancies exposed to tramadol not at heightened risk of miscarriage, congenital malformations
14 Mar 2022